Pro-atherosclerotic markers and cardiovascular risk factors one year after liver transplantation

Table 1 Demographic and clinical data from liver transplant recipients included n (%)

Variable	Results (n = 44)
Recipient age (yr)1	50.8 ± 14.3
Donor age (yr)1	41.9 ± 17.6
Gender
Male	29 (65.9)
Female	15 (34.1)
Etiology of liver disease1
HCV-related	16 (36.4)
Non-HCV-related	28 (63.6)
Patients with NAFLD	4 (9.1)
Patients with hepatocellular carcinoma	15 (34.1)
Pre-transplant MELD1	19.3 ± 9.4
Donor liver weight (g)1	1374.3 ± 311.3
Recipient liver weight (g)1	1399 ± 725.9
Cold ischemia time (min)1	400.9 ± 137.9
Warm ischemia time (min)1	47.2 ± 8.9
Intraoperative blood requirements1
Packed red cells (Units)	1.09 ± 1.6
Plasma (Units)	0.71 ± 1.8
Platelets (Units)	1.03 ± 3.53
Intraoperative albumin infusion (10 g bottles)1	4.32 ± 4.8
Tacrolimus-based immunosuppression	44 (100)
Steroids withdrawal (d)1	208.5 ± 106.8
Pre-transplant diabetes mellitus	16 (36.4)
Diabetes mellitus 1 yr after transplant	17 (38.6)
Pre-transplant BMI1	25.1 ± 5.3
BMI 1 yr after transplant1	24.3 ± 4.3
Abdominal circumference 1 yr after transplant (cm)1	89.4 ± 8.7
Tobacco consumption	8 (18.2)
Arterial hypertension	16 (36.4)
Sedentarism	28 (66.3)
Metabolic syndrome	10 (22.7)
Framingham risk score (10-yr)2	2.0 (1.0-8.75)

¹Mean and standard deviation;

²Median and 25^th-75^th percentiles. BMI: Body mass index.